Skip to main content
Top
Published in: Endocrine 3/2012

01-12-2012 | Letter to the Editor

Metformin and human uterine contractility

Authors: Mark P. Hehir, John J. Morrison

Published in: Endocrine | Issue 3/2012

Login to get access

Excerpt

Metformin is primarily used clinically in the treatment of type 2 diabetes mellitus but in recent years has been suggested as a treatment for gestational diabetes mellitus (GDM) [1]. It has also been increasingly prescribed in the treatment of polycystic ovarian syndrome, and for recurrent early pregnancy loss in women with PCOS. Although Metformin has been used with increasing frequency in GDM, due to a lack of complete clinical data, its use has not gained universal acceptance. Tight glycemic control during pregnancy has, however been shown to bring both fetal and maternal benefits in cases of type 1 and type 2 diabetes [2]. …
Literature
1.
go back to reference G. Hawthorne, Metformin use and diabetic pregnancy—has its time come? Diabet Med 23, 223–227 (2006)PubMedCrossRef G. Hawthorne, Metformin use and diabetic pregnancy—has its time come? Diabet Med 23, 223–227 (2006)PubMedCrossRef
2.
go back to reference J.A. Rowan, W.M. Hague, W. Gao, M.R. Battin, MiG Trial Investigators, Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 358(19), 2003–2015 (2008)PubMedCrossRef J.A. Rowan, W.M. Hague, W. Gao, M.R. Battin, MiG Trial Investigators, Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 358(19), 2003–2015 (2008)PubMedCrossRef
3.
go back to reference K. Cyganek, A. Hebda-Szydlo, J. Skupien, B. Katra, I. Janas, A. Borodako, I. Kaim, T. Klupa, A. Reron, M.T. Malecki, Glycemic control and pregnancy outcomes in women with type 2 diabetes from Poland. The impact of pregnancy planning and a comparison with type 1 diabetes subjects. Endocrine 40(2), 243–249 (2011)PubMedCrossRef K. Cyganek, A. Hebda-Szydlo, J. Skupien, B. Katra, I. Janas, A. Borodako, I. Kaim, T. Klupa, A. Reron, M.T. Malecki, Glycemic control and pregnancy outcomes in women with type 2 diabetes from Poland. The impact of pregnancy planning and a comparison with type 1 diabetes subjects. Endocrine 40(2), 243–249 (2011)PubMedCrossRef
4.
go back to reference W. Nicholson, K. Baptiste-Roberts, Oral hypoglycaemic agents during pregnancy: the evidence for effectiveness and safety. Best Pract Res Clin Obstet Gynaecol 25(1), 51–63 (2011)PubMedCrossRef W. Nicholson, K. Baptiste-Roberts, Oral hypoglycaemic agents during pregnancy: the evidence for effectiveness and safety. Best Pract Res Clin Obstet Gynaecol 25(1), 51–63 (2011)PubMedCrossRef
5.
go back to reference M.P. Hehir, A.T. Moynihan, J.J. Morrison, Relaxant effect of Levosimendan on human uterine contractility in vitro. Am J Obstet Gynecol 203(2), 184.e7–12 (2010). M.P. Hehir, A.T. Moynihan, J.J. Morrison, Relaxant effect of Levosimendan on human uterine contractility in vitro. Am J Obstet Gynecol 203(2), 184.e7–12 (2010).
Metadata
Title
Metformin and human uterine contractility
Authors
Mark P. Hehir
John J. Morrison
Publication date
01-12-2012
Publisher
Springer US
Published in
Endocrine / Issue 3/2012
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9687-y

Other articles of this Issue 3/2012

Endocrine 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.